Robot vs. electromagnetic navigation: which lung biopsy tool wins?

NCT ID NCT06654271

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two advanced bronchoscopy techniques—robotic assisted bronchoscopy and electromagnetic navigation bronchoscopy—to see which one more accurately diagnoses lung lesions. About 440 adults scheduled for a lung biopsy will be randomly assigned to one method. The main goal is to measure how often each method successfully collects tissue that explains the lesion.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Robotic assisted bronchoscopy (RAB) and electromagnetic navigation bronchoscopy (ENB) devices
What this could lead to
If one method proves clearly better, it could become the standard approach for diagnosing lung nodules, improving accuracy and reducing repeat procedures.
What could go wrong
This is a pragmatic trial comparing two existing technologies, so it is not testing a new treatment. The results may show no significant difference, or one method may only be better in specific cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NODULE, SOLITARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Johns Hopkins University

    Baltimore, Maryland, 21287, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37212, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.